ATE204473T1 - Pharmazeutische zusammensetzung, die gamma- hydroxybuttersäure oder das entsprechende lakton enthält, zur behandlung von drogenabhängigkeit und ernährungsstörungen - Google Patents

Pharmazeutische zusammensetzung, die gamma- hydroxybuttersäure oder das entsprechende lakton enthält, zur behandlung von drogenabhängigkeit und ernährungsstörungen

Info

Publication number
ATE204473T1
ATE204473T1 AT92912485T AT92912485T ATE204473T1 AT E204473 T1 ATE204473 T1 AT E204473T1 AT 92912485 T AT92912485 T AT 92912485T AT 92912485 T AT92912485 T AT 92912485T AT E204473 T1 ATE204473 T1 AT E204473T1
Authority
AT
Austria
Prior art keywords
treatment
hydroxybutry
acid
pharmaceutical composition
composition containing
Prior art date
Application number
AT92912485T
Other languages
English (en)
Inventor
Gaetano Crepaldi
Santo Ferrara
Luigi Gallimberti
Gian Luigi Gessa
Original Assignee
Gaetano Crepaldi
Santo Ferrara
Luigi Gallimberti
Gian Luigi Gessa
Ct Lab Farm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gaetano Crepaldi, Santo Ferrara, Luigi Gallimberti, Gian Luigi Gessa, Ct Lab Farm Srl filed Critical Gaetano Crepaldi
Application granted granted Critical
Publication of ATE204473T1 publication Critical patent/ATE204473T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92912485T 1991-06-28 1992-06-23 Pharmazeutische zusammensetzung, die gamma- hydroxybuttersäure oder das entsprechende lakton enthält, zur behandlung von drogenabhängigkeit und ernährungsstörungen ATE204473T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI911791A IT1248588B (it) 1991-06-28 1991-06-28 Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
PCT/EP1992/001409 WO1993000083A1 (en) 1991-06-28 1992-06-23 Pharmaceutical composition containing gamma-hydroxybutyric acid or its lactone in the treatment of drug dependence and nutritional disorders

Publications (1)

Publication Number Publication Date
ATE204473T1 true ATE204473T1 (de) 2001-09-15

Family

ID=11360230

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912485T ATE204473T1 (de) 1991-06-28 1992-06-23 Pharmazeutische zusammensetzung, die gamma- hydroxybuttersäure oder das entsprechende lakton enthält, zur behandlung von drogenabhängigkeit und ernährungsstörungen

Country Status (7)

Country Link
US (1) US5426120A (de)
EP (1) EP0563336B1 (de)
AT (1) ATE204473T1 (de)
AU (1) AU2018792A (de)
DE (1) DE69232016T2 (de)
IT (1) IT1248588B (de)
WO (1) WO1993000083A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
IT1283782B1 (it) * 1996-08-09 1998-04-30 Ct Lab Farm Srl Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo
AU779354B2 (en) 1998-12-23 2005-01-20 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
ATE255892T1 (de) * 1999-02-01 2003-12-15 Ortho Mcneil Pharm Inc Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa
RU2210360C1 (ru) * 2002-09-19 2003-08-20 Общество С Ограниченной Ответственностью "Консорциум-Пик" Психотропное средство
US8193211B2 (en) * 2004-09-30 2012-06-05 Supernus Pharmaceuticals, Inc. Controlled release compositions of gamma-hydroxybutyrate
FR2938431B1 (fr) * 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
DK2421808T3 (da) 2009-04-23 2013-11-04 Concert Pharmaceuticals Inc 4-Hydroxysmørsyreanaloger
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
KR101976218B1 (ko) * 2011-02-14 2019-05-07 콘서트 파마슈티컬즈, 인크. 4-히드록시부티르산 중수소화 유사체
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11000498B2 (en) 2016-07-22 2021-05-11 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD139519A1 (de) * 1978-11-10 1980-01-09 Annedore Wehl Verfahren zur herstellung analgetischer formulierungen mit verbesserten gebrauchswerteigenschaften
IT1217783B (it) * 1988-06-03 1990-03-30 Farmaceutico Ct S R L Lab Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative

Also Published As

Publication number Publication date
US5426120A (en) 1995-06-20
ITMI911791A1 (it) 1992-12-28
WO1993000083A1 (en) 1993-01-07
AU2018792A (en) 1993-01-25
EP0563336A1 (de) 1993-10-06
IT1248588B (it) 1995-01-19
EP0563336B1 (de) 2001-08-22
DE69232016D1 (de) 2001-09-27
ITMI911791A0 (it) 1991-06-28
DE69232016T2 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
DE69232016D1 (de) Pharmazeutische zusammensetzung, die gamma-hydroxybuttersäure oder das entsprechende lakton enthält, zur behandlung von drogenabhängigkeit und ernährungsstörungen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ES2097155T3 (es) Forma de dosificacion efervescente y metodo de administracion.
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
DK0706378T3 (da) Ny farmaceutisk formulering.
RU94046424A (ru) Способ разделения форм днказы, днказа человека, фармацевтическая композиция, способ хранения днказы, способ лечения
DE68916387D1 (de) Verwendung von Nalmefen oder Naltrexon bei der Behandlung von Autoimmunerkrankungen.
DK0430474T3 (da) Præparater med vedvarende frigivelse til behandling af periodontal sygdom
NO872991L (no) Legemiddelbaerer med forsinket frigivelse av medikament.
ATE133859T1 (de) Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
IT1222395B (it) Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DK598288A (da) Vaeskeformig farmaceutisk sammensaetning til behandling af hoste og oemhed i halsen
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
GUTELIUS et al. Treatment of pica with a vitamin and mineral supplement
DE3775854D1 (de) Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
Frederiksen et al. ACTH 4–9 analogue (ORG 2766) in depressed elderly patients: II. Effect on memory and vigilance
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
HENDERSON Questions about dantrolene for neuroleptic malignant syndrome
罗和春 et al. ELECTRO-ACUPUNCTURE VS. AMITRIPTYLINE IN THE TREATMENT OF DEPRESSIVE STATES
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.
Richmond et al. Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy: 6-Months’ Results

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee